Länder Analysen: Schweiz
| 17.06.21 | Givaudan Underperform | Bernstein Research | |
| 07.06.21 | Givaudan Underperform | Credit Suisse Group | |
| 04.06.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 21.05.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 19.05.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 18.05.21 | DocMorris Sell | UBS AG | |
| 18.05.21 | Givaudan Underweight | Barclays Capital | |
| 10.05.21 | Swiss Re Sell | UBS AG | |
|
Werbung
|
|||
| 30.04.21 | UBS Underweight | Barclays Capital | |
| 28.04.21 | Novartis Underweight | Barclays Capital | |
| 28.04.21 | ABB (Asea Brown Boveri) Sell | Deutsche Bank AG | |
| 28.04.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 28.04.21 | ABB (Asea Brown Boveri) Underweight | Morgan Stanley | |
| 27.04.21 | ABB (Asea Brown Boveri) Underweight | Morgan Stanley | |
| 27.04.21 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 27.04.21 | UBS Underweight | Barclays Capital | |
| 27.04.21 | DocMorris Sell | UBS AG | |
| 27.04.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 27.04.21 | Novartis Underweight | Barclays Capital | |
| 22.04.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 21.04.21 | DocMorris Sell | UBS AG | |
| 21.04.21 | UBS Underweight | Barclays Capital | |
| 16.04.21 | ABB (Asea Brown Boveri) Sell | Deutsche Bank AG | |
| 16.04.21 | Givaudan Underperform | Jefferies & Company Inc. | |
| 15.04.21 | ABB (Asea Brown Boveri) Underweight | Morgan Stanley | |
| 15.04.21 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 15.04.21 | ABB (Asea Brown Boveri) Underperform | Jefferies & Company Inc. | |
| 14.04.21 | Givaudan Sell | Goldman Sachs Group Inc. | |
| 14.04.21 | Swiss Re Sell | UBS AG | |
| 13.04.21 | Givaudan Sell | Goldman Sachs Group Inc. | |
| 13.04.21 | Givaudan Underperform | Jefferies & Company Inc. | |
| 12.04.21 | ABB (Asea Brown Boveri) Underweight | Morgan Stanley | |
| 09.04.21 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 09.04.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 07.04.21 | ABB (Asea Brown Boveri) Underperform | Jefferies & Company Inc. | |
| 07.04.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 06.04.21 | Givaudan Sell | Goldman Sachs Group Inc. | |
| 30.03.21 | DocMorris Sell | UBS AG | |
| 24.03.21 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 23.03.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 19.03.21 | DocMorris Sell | UBS AG | |
| 18.03.21 | DocMorris Sell | UBS AG | |
| 11.03.21 | Givaudan Underperform | Bernstein Research | |
| 22.02.21 | UBS Underweight | Barclays Capital | |
| 17.02.21 | Clariant Underweight | JP Morgan Chase & Co. | |
| 08.02.21 | ABB (Asea Brown Boveri) Sell | Deutsche Bank AG | |
| 05.02.21 | ABB (Asea Brown Boveri) Sell | Deutsche Bank AG | |
| 04.02.21 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 04.02.21 | ABB (Asea Brown Boveri) Sell | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 04.02.21 | ABB (Asea Brown Boveri) Underperform | Jefferies & Company Inc. | |